Literature DB >> 34510114

Trends in HIV prevalence by self-report among MSM diagnosed and reported with gonorrhea in six United States jurisdictions from 2010 to 2019.

Mark Richard Stenger1, Preeti Pathela2, Christina Schumacher3, Nicole Burghardt4, Rachel Amiya5, Robbie Madera6, Trang Q Nguyen7, Elizabeth Torrone1.   

Abstract

BACKGROUND: HIV co-infection among persons diagnosed with gonorrhea is not well characterized. Trends in HIV prevalence among persons diagnosed with gonorrhea may have significant implications for HIV prevention interventions, especially for MSM. MSM are increasingly and disproportionately represented among incident gonorrhea cases reported in a multistate sentinel surveillance network. Using data from this network, we estimated HIV prevalence among MSM by self-report and explored trends in co-infection by key demographics.
DESIGN: Observational study using enhanced surveillance data.
METHODS: Six geographically diverse jurisdictions in the STD Surveillance Network (SSuN) 2010-2019 randomly sampled laboratory-confirmed gonorrhea cases. Enhanced investigations on sampled cases included patient interviews eliciting demographic, behavioral and HIV testing history. These data were weighted to adjust for study design and nonresponse to estimate trends in HIV prevalence.
RESULTS: Of 653 522 reported cases, 28 979 were sampled and investigated. The proportion of cases reporting living with diagnosed HIV at the time of their gonorrhea diagnosis increased 61% across the study period from 6.6% in 2010 to 10.8% in 2019. The observed increase in HIV prevalence is concurrent with an increase in the proportion of gonorrhea cases attributable to MSM. HIV prevalence among MSM decreased in two jurisdictions and increasing trends were observed among non-Hispanic Black and Hispanic MSM. HIV prevalence decreased among non-Hispanic white MSM, MSM under 20 and those 40 years of age or older.
CONCLUSION: Diagnosis with gonorrhea, especially among MSM, should be a sentinel event triggering screening for HIV, referral to high-impact HIV prevention interventions or to HIV primary care.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34510114     DOI: 10.1097/QAD.0000000000003067

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  3 in total

1.  Effect of Screening and Treatment for Gonorrhea and Chlamydia on HIV Incidence Among Men Who Have Sex With Men in the United States: A Modeling Analysis.

Authors:  Jeb Jones; Adrien Le Guillou; Thomas L Gift; Harrell Chesson; Kyle T Bernstein; Kevin P Delaney; Cynthia Lyles; Andres Berruti; Patrick S Sullivan; Samuel M Jenness
Journal:  Sex Transm Dis       Date:  2022-07-29       Impact factor: 3.868

2.  Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection - United States, August 2022.

Authors:  Jesse O'Shea; Thomas D Filardo; Sapna Bamrah Morris; John Weiser; Brett Petersen; John T Brooks
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-08-12       Impact factor: 35.301

3.  Re: action to prevent monkeypox in Iran: special attention to men who have sex with men.

Authors:  Amir Kabir; Irwin Nazaret
Journal:  Clin Microbiol Infect       Date:  2022-09-20       Impact factor: 13.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.